Investment company H.I.G. Capital has agreed to sell Valtris Specialty Chemicals to an affiliate of funds managed by SK Capital Partners. Financial terms of the...
After making “good progress”, both strategically and financially, in the recent past, the next phase in Evonik’s drive toward enhanced business growth will see it execute...
EureKING, a new special purpose acquisition company (SPAC) steered by former European biopharma executives, launched itself on May 9 and in a subsequent listing on the...
Wacker Chemie has opened a new US regional innovation center in Ann Arbor, Michigan, dedicated to developing high-margin biotech and silicone specialties for high-tech...
When the pandemic was pounding at their doors, many industries were rattled. Healthcare and chemicals were adapting rather successfully to the new normal, as a McKinsey &...
Supply chain visibility (SCV) seems to be on everyone’s agenda right now. However, when talking to companies, it quickly becomes clear that everyone has a different...
Major drugmaker Pfizer has agreed to buy US biotech Biohaven Pharmaceutical for around $11.6 billion. Founded in 2013 and based in New Haven, Connecticut, Biohaven...
US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this...
